Insights

Expansion into vaccine manufacturing Emergent BioSolutions recently made a strategic investment in RocketVax AG, a subsidiary of Swiss Rockets, focused on vaccine manufacturing. This partnership presents an opportunity for cross-selling vaccine-related products or services to RocketVax AG and its network.

Facility sale to Syngene Emergent BioSolutions sold its Baltimore-Bayview drug substance manufacturing facility to Syngene International for $36.5 million. This transaction could open up sales opportunities to offer services or products to Syngene as they expand their operations.

Attendance at Healthcare Conference Emergent BioSolutions attended the 43rd Annual J.P. Morgan Healthcare Conference. This event participation could indicate potential market visibility and networking opportunities to showcase products or solutions to industry stakeholders.

Investment by Jacobs Levy Equity Jacobs Levy Equity Management Inc. invested $1.55 million in Emergent BioSolutions. This financial backing could signal confidence in the company's growth potential, presenting opportunities for partnership or collaboration discussions.

Securing credit facility from Wells Fargo Emergent BioSolutions secured a $100 million credit facility from Wells Fargo Bank to enhance liquidity and support business transformation. This financial backing could provide stability for future growth and potential opportunities for investment or partnership discussions.

Emergent BioSolutions Tech Stack

Emergent BioSolutions uses 8 technology products and services including Module Federation, jQuery Migrate, ServiceNow, and more. Explore Emergent BioSolutions's tech stack below.

  • Module Federation
    Development
  • jQuery Migrate
    Javascript Libraries
  • ServiceNow
    Miscellaneous
  • Cisco
    Network Hardware
  • Windows 10
    Operating Systems
  • Priority Hints
    Performance
  • Microsoft Azure
    Platform As A Service
  • C#
    Programming Languages

Media & News

Emergent BioSolutions's Email Address Formats

Emergent BioSolutions uses at least 3 format(s):
Emergent BioSolutions Email FormatsExamplePercentage
LastF@ebsi.comDoeJ@ebsi.com
81%
FLast@ebsi.comJDoe@ebsi.com
6%
FirstL@ebsi.comJohnD@ebsi.com
2%
Last@ebsi.comDoe@ebsi.com
1%
First.Last@ebsi.comJohn.Doe@ebsi.com
1%
F-Last@ebsi.comJ-Doe@ebsi.com
1%
F.Last@ebsi.comJ.Doe@ebsi.com
1%
Last.First@ebsi.comDoe.John@ebsi.com
1%
LFirst@ebsi.comDJohn@ebsi.com
1%
Last.F@ebsi.comDoe.J@ebsi.com
1%
First_Last@ebsi.comJohn_Doe@ebsi.com
1%
FirLast@ebsi.comJohDoe@ebsi.com
1%
FirstLas@ebsi.comJohnDoe@ebsi.com
1%
FiLast@ebsi.comJoDoe@ebsi.com
1%
FLast@paxvax.comJDoe@paxvax.com
73%
Last@paxvax.comDoe@paxvax.com
8%
FirstLast@paxvax.comJohnDoe@paxvax.com
3%
FirLast@paxvax.comJohDoe@paxvax.com
4%
First-Last@paxvax.comJohn-Doe@paxvax.com
2%
Last.First@paxvax.comDoe.John@paxvax.com
2%
FirstMiddleLast@paxvax.comJohnMichaelDoe@paxvax.com
2%
First.Last@paxvax.comJohn.Doe@paxvax.com
2%
Last_First@paxvax.comDoe_John@paxvax.com
1%
First_Last@paxvax.comJohn_Doe@paxvax.com
1%
FMiddleLast@paxvax.comJMichaelDoe@paxvax.com
1%
F-Last@paxvax.comJ-Doe@paxvax.com
1%
First.Last@emergentbiosolutions.comJohn.Doe@emergentbiosolutions.com
75%
LastF@emergentbiosolutions.comDoeJ@emergentbiosolutions.com
11%
First_Last@emergentbiosolutions.comJohn_Doe@emergentbiosolutions.com
9%
First.L@emergentbiosolutions.comJohn.D@emergentbiosolutions.com
5%

Frequently Asked Questions

Where is Emergent BioSolutions's headquarters located?

Minus sign iconPlus sign icon
Emergent BioSolutions's main headquarters is located at 300 Professional Dr Gaithersburg, Maryland 20879 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Emergent BioSolutions's phone number?

Minus sign iconPlus sign icon
You can contact Emergent BioSolutions's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Emergent BioSolutions's stock symbol?

Minus sign iconPlus sign icon
Emergent BioSolutions is a publicly traded company; the company's stock symbol is EBS.

What is Emergent BioSolutions's official website and social media links?

Minus sign iconPlus sign icon
Emergent BioSolutions's official website is emergentbiosolutions.com and has social profiles on LinkedIn.

How much revenue does Emergent BioSolutions generate?

Minus sign iconPlus sign icon
As of April 2025, Emergent BioSolutions's annual revenue reached $1B.

What is Emergent BioSolutions's SIC code NAICS code?

Minus sign iconPlus sign icon
Emergent BioSolutions's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Emergent BioSolutions have currently?

Minus sign iconPlus sign icon
As of April 2025, Emergent BioSolutions has approximately 1.5K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: H. J.Chief Executive Officer President: K. S.Chief Human Resources Officer: M. P.. Explore Emergent BioSolutions's employee directory with LeadIQ.

What industry does Emergent BioSolutions belong to?

Minus sign iconPlus sign icon
Emergent BioSolutions operates in the Biotechnology Research industry.

What technology does Emergent BioSolutions use?

Minus sign iconPlus sign icon
Emergent BioSolutions's tech stack includes Module FederationjQuery MigrateServiceNowCiscoWindows 10Priority HintsMicrosoft AzureC#.

What is Emergent BioSolutions's email format?

Minus sign iconPlus sign icon
Emergent BioSolutions's email format typically follows the pattern of . Find more Emergent BioSolutions email formats with LeadIQ.

How much funding has Emergent BioSolutions raised to date?

Minus sign iconPlus sign icon
As of April 2025, Emergent BioSolutions has raised $250M in funding. The last funding round occurred on Aug 30, 2024 for $250M.

When was Emergent BioSolutions founded?

Minus sign iconPlus sign icon
Emergent BioSolutions was founded in 1998.
Emergent BioSolutions

Emergent BioSolutions

Biotechnology ResearchMaryland, United States1001-5000 Employees

At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do.

Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud

Section iconCompany Overview

Headquarters
300 Professional Dr Gaithersburg, Maryland 20879 US
Phone number
SIC Code
2836 - Biological Products, Except Diagnostic Substances
Stock Symbol
EBS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
1001-5000

Section iconFunding & Financials

  • $250M

    Emergent BioSolutions has raised a total of $250M of funding over 5 rounds. Their latest funding round was raised on Aug 30, 2024 in the amount of $250M.

  • $1B

    Emergent BioSolutions's revenue is in the range of $1B

Section iconFunding & Financials

  • $250M

    Emergent BioSolutions has raised a total of $250M of funding over 5 rounds. Their latest funding round was raised on Aug 30, 2024 in the amount of $250M.

  • $1B

    Emergent BioSolutions's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.